IFNA14 and HIV infectious disease: A comparable study in humanized mice with pasylated IFNα14 showed no effect of single IFNα14 treatment during chronic HIV infection; however, previous cART reduced ISG expression in chronically infected mice, and subsequent IFNα14 therapy resulted in a transiently lower HIV burden [81].